June 2015: The European Commission experts that have evaluated the proposal emphasize that NEOS has been able to identify and solve an unmet clinical need. This shows the company’s strong growth potential. According to NEOS’ Managing Director, Lluís Chico, “the expectations on the project and on NEOS’ progress are high, and we are confident that we will be able to meet them”.
